Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARK: Atorvastatin Postpartum for Reduction of Cardiovascular Risk
NCT06632379Phase 4Recruiting
- Sponsor
- The Ohio State University
- Start
- Oct 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in hypertensive disorders of pregnancy (HDP), sponsored by The Ohio State University. Started Oct 2025; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
hypertensive disorders of pregnancy (HDP)
Beyond the preview
Go deeper on NCT06632379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06632379.